Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001494650-24-000154
Filing Date
2024-11-12
Accepted
2024-11-12 08:02:38
Documents
73
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q optn-20240930.htm   iXBRL 10-Q 1000127
2 EX-31.1 optinose09-30x202410xqrm30.htm EX-31.1 8270
3 EX-31.2 optinose09-30x202410xqtk30.htm EX-31.2 8275
4 EX-32.1 optinose9-30x202410xqrm906.htm EX-32.1 6098
5 EX-32.2 optinose9-30x202410xqtk906.htm EX-32.2 6203
11 optn-20240930_g1.jpg GRAPHIC 10067
12 optn-20240930_g2.jpg GRAPHIC 83837
  Complete submission text file 0001494650-24-000154.txt   5894567

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT optn-20240930.xsd EX-101.SCH 43013
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT optn-20240930_cal.xml EX-101.CAL 52405
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT optn-20240930_def.xml EX-101.DEF 232999
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT optn-20240930_lab.xml EX-101.LAB 497097
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT optn-20240930_pre.xml EX-101.PRE 369511
75 EXTRACTED XBRL INSTANCE DOCUMENT optn-20240930_htm.xml XML 718093
Mailing Address 777 TOWNSHIP LINE ROAD SUITE 300 YARDLEY PA 19067
Business Address 777 TOWNSHIP LINE ROAD SUITE 300 YARDLEY PA 19067 267-364-3500
OptiNose, Inc. (Filer) CIK: 0001494650 (see all company filings)

EIN.: 421771610 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38241 | Film No.: 241443524
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)